Cited 0 times in Scipus Cited Count

Efficacy and safety of non-vitamin K-antagonist oral anticoagulants for retinal vascular diseases in patients with atrial fibrillation: Korean cohort study

DC Field Value Language
dc.contributor.authorPark, SJ-
dc.contributor.authorLee, E-
dc.contributor.authorLee, K-
dc.contributor.authorPark, B-
dc.contributor.authorChung, YR-
dc.date.accessioned2022-11-23T07:32:45Z-
dc.date.available2022-11-23T07:32:45Z-
dc.date.issued2020-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/22821-
dc.description.abstractWe investigated the prevalence of retinal vascular occlusion and intraocular bleeding and compare their risks in patients undergoing anticoagulant therapy, either with non-vitamin K-antagonist oral anticoagulants (NOAC) or warfarin. We performed a cohort study (January 2015 to April 2018) in 281,970 patients with nonvalvular atrial fibrillation (AF) using health claims in the nationwide database of the Health Insurance Review and Assessment service of Korea. A Cox-proportional hazard regression was used to calculate the hazard ratio (HR) for retinal vascular occlusion or intraocular bleeding. The HR of retinal vascular occlusion was estimated to 1.59 (95% confidence interval [CI], 1.35-1.86) for NOAC users compared to that with warfarin users. Among the various types of NOACs, all NOACs showed higher risk of retinal vascular occlusion than did warfarin. For intraocular bleeding, the HR was estimated to be 0.86 (95% CI, 0.75-0.98) for NOAC users compared with that with warfarin users. The risk of retinal vascular occlusion was higher in NOAC users than in warfarin users, while the risk of intraocular bleeding was lower with NOAC therapy. NOACs were not found to be as effective as warfarin for retinal vascular occlusion, but safe in terms of intraocular bleeding.-
dc.language.isoen-
dc.subject.MESHAdministration, Oral-
dc.subject.MESHAged-
dc.subject.MESHAnticoagulants-
dc.subject.MESHAtrial Fibrillation-
dc.subject.MESHCohort Studies-
dc.subject.MESHEye Hemorrhage-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHInsurance Claim Review-
dc.subject.MESHMale-
dc.subject.MESHPrevalence-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHRetinal Vein Occlusion-
dc.subject.MESHWarfarin-
dc.titleEfficacy and safety of non-vitamin K-antagonist oral anticoagulants for retinal vascular diseases in patients with atrial fibrillation: Korean cohort study-
dc.typeArticle-
dc.identifier.pmid32165726-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067845-
dc.subject.keywordAtrial fibrillation-
dc.subject.keywordRetinal diseases-
dc.contributor.affiliatedAuthorLee, K-
dc.contributor.affiliatedAuthorPark, B-
dc.contributor.affiliatedAuthorChung, YR-
dc.type.localJournal Papers-
dc.identifier.doi10.1038/s41598-020-61609-8-
dc.citation.titleScientific reports-
dc.citation.volume10-
dc.citation.number1-
dc.citation.date2020-
dc.citation.startPage4577-
dc.citation.endPage4577-
dc.identifier.bibliographicCitationScientific reports, 10(1). : 4577-4577, 2020-
dc.identifier.eissn2045-2322-
dc.relation.journalidJ020452322-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Ophthalmology
Journal Papers > School of Medicine / Graduate School of Medicine > Biomedical Informatics
Files in This Item:
32165726.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse